Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-08-000019
Filing Date
2008-05-23
Accepted
2008-05-23 11:35:30
Documents
1
Period of Report
2008-05-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 4  
1 PRIMARY DOCUMENT doc.xml 4 3861
  Complete submission text file 0000882796-08-000019.txt   5860
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENAERA CORP 5110 CAMPUS DDRIVE PLYMOUTH MEETING PA 19462
Business Address C/O GENAERA CORP 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 610 941 4020
HOROVITZ ZOLA P (Reporting) CIK: 0001033507 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 08856919